Abstract
Adjuvant chemotherapy of gastric cancer after curative resection is still subject to discussion. In this study 137 patients with gastric adenocarcinoma, all with positive nodes, were randomized after curative resection so that 69 received epidoxorubicin (EPI), leucovorin (LV) and 5-fluorouracil (5-FU) on days 1–3 every 3 weeks for 7 months, whereas the remaining 68 did not. After a follow-up period of 5 years, 21 of the 69 treated patients (30%) and nine controls (13%) were still alive; median survival time was 18 months for the controls and 31 months for the patients treated with adjuvant chemotherapy (P< 0.01). © 2001 Cancer Research Campaign http://www.bjcancer.com
Keywords: adjuvant chemotherapy, epidoxorubicin, 5-fluorouracil, gastric cancer, leucovorin, randomized trial
Full Text
The Full Text of this article is available as a PDF (54.3 KB).